| 1 |
Couvineau A, Voisin T, Nicole P, Gratio V, Blais A. Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol 2021; 27(44): 7582-7596 [PMID: 34908800 DOI: 10.3748/wjg.v27.i44.7582] [Reference Citation Analysis]
|
| 2 |
Watts AG, Kanoski SE, Sanchez-Watts G, Langhans W. The Physiological Control of Eating: Signals, Neurons, and Networks. Physiol Rev 2021. [PMID: 34486393 DOI: 10.1152/physrev.00028.2020] [Reference Citation Analysis]
|
| 3 |
Castro DC, Bruchas MR. A Motivational and Neuropeptidergic Hub: Anatomical and Functional Diversity within the Nucleus Accumbens Shell. Neuron 2019;102:529-52. [PMID: 31071288 DOI: 10.1016/j.neuron.2019.03.003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 17.7] [Reference Citation Analysis]
|
| 4 |
Berthoud HR, Morrison CD, Münzberg H. The obesity epidemic in the face of homeostatic body weight regulation: What went wrong and how can it be fixed? Physiol Behav 2020;222:112959. [PMID: 32422162 DOI: 10.1016/j.physbeh.2020.112959] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 5 |
Guillaumin MCC, Burdakov D. Neuropeptides as Primary Mediators of Brain Circuit Connectivity. Front Neurosci 2021;15:644313. [PMID: 33776641 DOI: 10.3389/fnins.2021.644313] [Reference Citation Analysis]
|
| 6 |
James MH, Aston-Jones G. Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?". Brain Res 2020;1731:146665. [PMID: 31930996 DOI: 10.1016/j.brainres.2020.146665] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 7 |
Wang C, Chen M, Qin C, Qu X, Shen X, Liu S. Lateral Hypothalamic Orexin Neurons Mediate the Reward Effects of Pain Relief Induced by Electroacupuncture. Front Mol Neurosci 2022;15:812035. [DOI: 10.3389/fnmol.2022.812035] [Reference Citation Analysis]
|
| 8 |
Peleg-Raibstein D, Burdakov D. Do orexin/hypocretin neurons signal stress or reward? Peptides 2021;145:170629. [PMID: 34416308 DOI: 10.1016/j.peptides.2021.170629] [Reference Citation Analysis]
|
| 9 |
James MH, Fragale JE, O'Connor SL, Zimmer BA, Aston-Jones G. The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse. Neuropharmacology 2021;183:108359. [PMID: 33091458 DOI: 10.1016/j.neuropharm.2020.108359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 10 |
Um YH, Lim HK. Orexin and Alzheimer's Disease: A New Perspective. Psychiatry Investig 2020;17:621-6. [PMID: 32517419 DOI: 10.30773/pi.2020.0136] [Reference Citation Analysis]
|
| 11 |
Concetti C, Burdakov D. Orexin/Hypocretin and MCH Neurons: Cognitive and Motor Roles Beyond Arousal. Front Neurosci 2021;15:639313. [PMID: 33828450 DOI: 10.3389/fnins.2021.639313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Pulver A, Kiive E, Kanarik M, Harro J. Association of orexin/hypocretin receptor gene (HCRTR1) with reward sensitivity, and interaction with gender. Brain Res 2020;1746:147013. [PMID: 32652147 DOI: 10.1016/j.brainres.2020.147013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 13 |
Garau C, Blomeley C, Burdakov D. Orexin neurons and inhibitory Agrp→orexin circuits guide spatial exploration in mice. J Physiol 2020;598:4371-83. [PMID: 32667686 DOI: 10.1113/JP280158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
|
